[Federal Register Volume 64, Number 123 (Monday, June 28, 1999)]
[Notices]
[Page 34681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-16261]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Registration
By Notice dated March 18, 1999, and published in the Federal
Register on April 1, 1999, (64 FR 15807), Johnson Matthey, Inc., Custom
Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey
08066, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Difenoxin (9168)........................... I
Propiram (9649)............................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Alfentanil (9737).......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The firm plans to manufacture the listed controlled substances in
bulk to supply final dosage form manufacturers.
DEA has considered the factors in Title 21, United States Code,
Section 823(a) and determined that the registration of Johnson Matthey,
Inc. to manufacture listed controlled substances is consistent with the
public interest at this time. DEA has investigated Johnson Matthey,
Inc. on a regular basis to ensure that the company's continued
registration is consistent with the public interest. These
investigations have included inspection and testing of the company's
physical security systems, audits of the company's records,
verification of the company's physical security systems, audits of the
company's records, verification of the company's compliance with state
and local laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the
Deputy Assistant Administrator, Office of Diversion Control, hereby
orders that the application submitted by the above firm for
registration as a bulk manufacturer of the basic classes of controlled
substances listed above is granted.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 99-16261 Filed 6-25-99; 8:45 am]
BILLING CODE 4410-09-M
